drugset / Trial / NCT05230290
Clinical Study of KD6001 in Advanced Solid Tumours
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and clinical activity of KD6001 as treatment for participants with advanced solid tumours.
Timeline
- Start
- 2020-09-10
- Primary completion
- 2022-07-20
- Completion
- 2022-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KD6001 | Unknown | — | Intravenous |